Critical Insights From Owens & Minor Analyst Ratings: What You Need To Know
Portfolio Pulse from Benzinga Insights
Owens & Minor (NYSE:OMI) received mixed analyst ratings with a recent shift towards neutrality. The average 12-month price target increased to $25.25 from $23.50. Analysts from Citigroup, Barclays, and UBS adjusted their ratings and price targets, reflecting varied expectations. Owens & Minor's financials show positive revenue growth and strong profitability metrics, despite challenges in debt management. The company operates in medical supplies distribution and manufacturing.
February 21, 2024 | 5:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Owens & Minor received mixed analyst ratings, with a recent average price target increase to $25.25. Financials indicate positive revenue growth and strong profitability, despite high debt levels.
The mixed analyst ratings with a recent shift towards neutrality and the increase in the average price target suggest a cautious optimism among analysts. The positive revenue growth and strong profitability metrics indicate a solid operational performance, which could support the stock price. However, the high debt levels present a risk, making the overall short-term impact neutral.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100